Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Affimed N.V. (AFMD)

Affimed N.V. (AFMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Affimed N.V.: Q1 Earnings Snapshot AP - Wed Jun 12, 5:41AM CDT

Affimed N.V.: Q1 Earnings Snapshot

AFMD : 5.03 (-1.28%)
Affimed N.V.: Q3 Earnings Snapshot AP - Tue Nov 14, 2023

Affimed N.V.: Q3 Earnings Snapshot

AFMD : 5.03 (-1.28%)
Affimed N.V.: Q2 Earnings Snapshot AP - Thu Aug 10, 2023

Affimed N.V.: Q2 Earnings Snapshot

AFMD : 5.03 (-1.28%)
Affimed N.V.: Q1 Earnings Snapshot AP - Tue May 23, 2023

Affimed N.V.: Q1 Earnings Snapshot

AFMD : 5.03 (-1.28%)
Why Shares of Affimed Fell Thursday Motley Fool - Thu Nov 17, 2022

The clinical-stage biotech focuses on immuno-oncology therapies.

AFMD : 5.03 (-1.28%)
Affimed N.V.: Q3 Earnings Snapshot AP - Tue Nov 15, 2022

Affimed N.V.: Q3 Earnings Snapshot

AFMD : 5.03 (-1.28%)
Why Affimed Stock Plummeted by Over 16% Today Motley Fool - Mon Oct 10, 2022

An analyst's downgrade brings out the bears for the European cancer treatment developer.

AFMD : 5.03 (-1.28%)
SF : 82.41 (-1.23%)
Billionaires Are Scooping Up These 3 Beaten-Down Biotech Stocks Motley Fool - Wed Aug 24, 2022

This billionaire-guided hedge fund went bargain-shopping in the second quarter.

AFMD : 5.03 (-1.28%)
CERS : 1.7000 (-1.16%)
REPL : 8.11 (+0.25%)
Affimed Reports Second Quarter 2022 Financial Results and Highlights Recent Operational Progress Globe Newswire - Thu Aug 11, 2022

AFM13 monotherapy: On track to report topline data of the registration-directed REDIRECT trial in the fourth quarter of 2022AFM13 combination with natural...

AFMD : 5.03 (-1.28%)
Affimed to Report Second Quarter 2022 Financial Results & Corporate Update on August 11, 2022 Globe Newswire - Thu Aug 4, 2022

HEIDELBERG, Germany, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage immuno-oncology...

AFMD : 5.03 (-1.28%)

Barchart Exclusives

3 Standout Stocks to Buy for Q3 2024 Barchart - Fri Jul 5, 2:05PM CDT
As we enter the third quarter of 2024, here are three promising stocks investors could consider buying. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot